Fulvestrant: A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

By Croxtall Jamie D.   McKeage Kate  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 363-380

Adis International

Access to resources Recommend Favorite

Trastuzumab: In HER2 and Hormone Receptor Co-Positive Metastatic Breast Cancer

By Orman Jennifer S.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2781-2789

Adis International

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy

By McKeage K.   Curran M.P.   Plosker G.L.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer

By Montemurro Filippo   Rossi Valentina   Geuna Elena   Valabrega Giorgio   Martinello Rossella   Milani Andrea   Aglietta Massimo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2143-2156

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

By Fabi Alessandra   Merola Roberta   Ferretti Gianluigi   Di Benedetto Anna   Antoniani Barbara   Ercolani Cristiana   Nisticò Cecilia   Papaldo Paola   Ciccarese Mariangela   Sperduti Isabella   Vici Patrizia   Marino Mirella   Gori Stefania   Botti Claudio   Malaguti Paola   Cognetti Francesco   Mottolese Marcella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 699-706

Informa Healthcare

Access to resources Recommend Favorite